Correction: Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa

Affiliations

• ¹ Department of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
• ² Ocugen Inc., Malvern, PA, USA.
• ³ Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA.
• ⁴ Moran Eye Center for Translational Medicine, Salt Lake, UT, USA.
• ⁵ Department of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. neena_haider@meei.harvard.edu.